Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.

MLA

van den Berg, Victor J., et al. “Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.” Circulation, vol. 134, no. 13, Sept. 2016, pp. 984–86. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.116.023480.

APA

van den Berg, V. J., Umans, V. A. W. M., Stam, F., de Mulder, M., Akkerhuis, K. M., Cornel, J. H., Kardys, I., & Boersma, E. (2016). Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome. Circulation, 134(13), 984–986. https://doi.org/10.1161/CIRCULATIONAHA.116.023480

Chicago

van den Berg, Victor J., Victor A. W. M. Umans, Frank Stam, Maarten de Mulder, K. Martijn Akkerhuis, Jan H. Cornel, Isabella Kardys, and Eric Boersma. 2016. “Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.” Circulation 134 (13): 984–86. doi:10.1161/CIRCULATIONAHA.116.023480.